Introduction On July 20, 2018 in Saint Regis Mohawk Tribe, Allergan, Inc. v. Mylan Pharmaceuticals Inc., a panel of the U.S. Court of Appeals for the Federal Circuit (Dyk, Moore and Reyna JJ) held that Native American (“Indian”) Tribes...
Read ArticleOn April 23, 2019, the following amendments to the Trademark Law of the People’s Republic of China (PRC) were approved that should significantly help trademark owners defend their rights: Trademark applications filed in bad faith without an...
Read ArticleKeeping Intellectual Property (IP) recordal projects under control can sometimes be a daunting task. With the exception of certain transactions, such as stock purchase agreements, recently acquired intellectual property rights likely need to be...
Read ArticleRecent unsolicited notices have been sent to U.S. trademark owners from a third party calling itself “Patent and Trademark Office”. Like other similar third party solicitations, about which the U.S. Patent and Trademark Office continues...
Read ArticleLadas & Parry LLP considers diversity and inclusion as core values and principles that provide access to opportunity and ensure excellence, particularly in the IP field. We salute those who have helped shape the world and would like to shine a...
Read ArticleIn Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc, the United States Supreme Court held that a prior public sale of a patented product could destroy the novelty of a patent for that product even though there was no disclosure of the...
Read Article